In today’s globalized pharma environment, technical and supply chain challenges in the clinical trial process create ripple effects felt by stakeholders across regions and functions. This has created ...

The Europe clinical trials market offers growth opportunities through a strong regulatory framework and rising R&D ...

SEATTLE--(BUSINESS WIRE)-- Omeros Corporation (OMER) today reported that clinical trial site activation for enrollment is underway for the company’s Phase 3 program evaluating zaltenibart in ...

Luci indicated the company is focused on securing additional funding opportunities to support the Phase 3 ibezapolstat clinical trial program and expects further updates on funding initiatives in ...

The KaiNETIC global Phase 3 clinical program includes three global, double-blind, randomized, placebo-controlled Phase 3 trials (KaiNETIC-1, KaiNETIC-2, and KaiNETIC-3) to evaluate weekly ribupatide ...

Luci explained that efforts to secure partnerships, including with government agencies, are ongoing and "will certainly slip into 2026, given the dynamics that are going on in Washington," but ...

Cabaletta Bio, Inc. announced promising results from its ongoing RESET clinical trials for its investigational therapy rese-cel, focusing on autoimmune diseases. In the trials, notable outcomes ...

VYNE Therapeutics Inc. has provided an update on its clinical program for VYN202, an oral small molecule BET inhibitor aimed at treating moderate-to-severe plaque psoriasis. Following a clinical hold ...